Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Application is based on Phase 2b/3 SELECTION study data with patients with moderately to severely…
Inverite Attends CLA’s Automotive Finance Canada 2026 as Industry Focus Intensifies on Fraud, Digital Approvals, and Stronger Risk Signals
TempraMed Partners with Super-Pharm, Israel’s Leading Pharmacy Chain to Commence a National Product Roll Out Strategy
Imagen Network Signals a Shift Toward Intelligence-Driven Digital Creativity
BeWhere Unveils BeBatt: 5th-Generation IoT Asset Tracker Delivering 10+ Years Battery Life at Unprecedented Price Points
ALUULA Delivers Record Fiscal 2025 Results and Profitable Quarter